RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
USANA Health Sciences Stock

USANA Health Sciences ROE 2024

USANA Health Sciences ROE

0.13

Ticker

USNA

ISIN

US90328M1071

WKN

923145

In 2024, USANA Health Sciences's return on equity (ROE) was 0.13, a -19.68% increase from the 0.16 ROE in the previous year.

USANA Health Sciences Aktienanalyse

What does USANA Health Sciences do?

USANA Health Sciences Inc is an American company that was founded in 1992 by Dr. Myron Wentz. Originally headquartered in Salt Lake City, Utah, the company now operates in over 20 countries worldwide. The main mission of USANA is to help people live healthier lives through high-quality supplements and a healthy lifestyle. USANA is a direct sales company, which means that its products are sold by independent distributors. These distributors earn a commission on their sales and can also have additional income opportunities by building a network of distributors. USANA's business model is based on the idea that people can improve their well-being and enhance their lives by using high-quality supplements and adopting a healthy lifestyle. USANA offers a wide range of products in various categories, including supplements for adults and children, weight management products, personalized vitamins and minerals, skincare products, as well as energy and fitness products. The quality of USANA's products is ensured through strict quality assurance measures and independent certification by NSF International, a third-party company that verifies the safety and efficacy of supplements. USANA also has several divisions, including USANA Health Sciences, Inc., USANA Pacific, Ltd., and BabyCare Ltd. USANA Health Sciences, Inc. is the company's main focus, specializing in the development and distribution of health-related products. USANA Pacific Ltd. is a wholly independent company that focuses on developing and distributing products for customers in Australia, New Zealand, and Asia. BabyCare Ltd. is a company specialized in manufacturing skincare products for babies. USANA has also established a charitable organization, the USANA Foundation, to carry out philanthropic work in various communities around the world. The USANA Foundation addresses basic needs such as health, education, and nutrition and supports organizations dedicated to helping children in need. In summary, USANA Health Sciences Inc is a company that is dedicated to improving people's health and well-being. Its direct sales model and use of high-quality ingredients and supplements certified by an independent third party have helped to build consumer trust in USANA's products. USANA has also expanded its reach through the establishment of various divisions and the creation of a charitable organization, allowing it to have a positive impact on many people worldwide. USANA Health Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding USANA Health Sciences's Return on Equity (ROE)

USANA Health Sciences's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing USANA Health Sciences's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

USANA Health Sciences's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in USANA Health Sciences’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about USANA Health Sciences stock

What is the ROE (Return on Equity) of USANA Health Sciences this year?

The ROE of USANA Health Sciences this year is 0.13 undefined.

How has the Return on Equity (ROE) of USANA Health Sciences developed compared to the previous year?

The ROE of USANA Health Sciences has increased by -19.68% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of USANA Health Sciences?

A high ROE indicates that USANA Health Sciences generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of USANA Health Sciences?

A low ROE can indicate that USANA Health Sciences is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of USANA Health Sciences affect the company?

A change in ROE (Return on Equity) of USANA Health Sciences can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of USANA Health Sciences?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of USANA Health Sciences?

Some factors that can influence USANA Health Sciences's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does USANA Health Sciences pay?

Over the past 12 months, USANA Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, USANA Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of USANA Health Sciences?

The current dividend yield of USANA Health Sciences is .

When does USANA Health Sciences pay dividends?

USANA Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of USANA Health Sciences?

USANA Health Sciences paid dividends every year for the past 0 years.

What is the dividend of USANA Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is USANA Health Sciences located?

USANA Health Sciences is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von USANA Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of USANA Health Sciences from 12/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/7/2024.

When did USANA Health Sciences pay the last dividend?

The last dividend was paid out on 12/7/2024.

What was the dividend of USANA Health Sciences in the year 2023?

In the year 2023, USANA Health Sciences distributed 0 USD as dividends.

In which currency does USANA Health Sciences pay out the dividend?

The dividends of USANA Health Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von USANA Health Sciences

Our stock analysis for USANA Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of USANA Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.